Loading clinical trials...
Loading clinical trials...
This study will evaluate the long-term safety and tolerability of intermittent treatment with ubrogepant for the acute treatment of migraine over 1 year.
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Allergan
NCT03237845 · Migraine, With or Without Aura
NCT03461757 · Migraine, With or Without Aura
NCT02867709 · Migraine, With or Without Aura
NCT02848326 · Migraine, With or Without Aura
Radiant Research, Inc.
Birmingham, Alabama
East Family Physicians PC/Radiant Research, Inc.
Chandler, Arizona
Desert Clinical Research /Radiant Research, Inc.
Mesa, Arizona
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions